Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.

Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.

[This corrects the article DOI: 10.1371/journal.ppat.1006796.].

Saved in:

Bibliographic Details
Main Authors:	Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova, Matthew Angel, Javier G Magadán, Hang Xie, Christopher B Brooke, Jonathan W Yewdell
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-06-01
Series:	PLoS Pathogens
Online Access:	https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007141&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multivalent interactions between fully glycosylated influenza virus hemagglutinins mediated by glycans at distinct N-glycosylation sites
by: Ruofan Li, et al.
Published: (2024-10-01)

Characterization of antigenically dominant regions in the hemagglutinin protein of B/victoria-lineage influenza B virus using monoclonal antibody escape mutants
by: Yoko Matsuzaki, et al.
Published: (2025-08-01)

Hemagglutinin glycosylation pattern-specific effects: implications for the fitness of H9.4.2.5-branched H9N2 avian influenza viruses
by: Yixue Sun, et al.
Published: (2024-12-01)

Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
by: Aziza P Manceur, et al.
Published: (2017-01-01)

The emergence of new antigen branches of H9N2 avian influenza virus in China due to antigenic drift on hemagglutinin through antibody escape at immunodominant sites
by: Nan Zhang, et al.
Published: (2023-12-01)

Adsorptive mutation and N-linked glycosylation modulate influenza virus antigenicity and fitness
by: Joshua E. Sealy, et al.
Published: (2020-01-01)

Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in Epidemic Season 2023/2024 in Poland
by: Katarzyna Kondratiuk, et al.
Published: (2025-07-01)

Leveraging large language models to predict antibody biological activity against influenza A hemagglutinin
by: Ella Barkan, et al.
Published: (2025-01-01)

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses
by: Arne Matthys, et al.
Published: (2025-07-01)

Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses
by: Anthony L. Desbien, et al.
Published: (2013-06-01)

Antibody Response to Influenza Hemagglutinin Conserved Stalk Domain after Sequential Immunization with Old Vaccine Strains
by: Alita Kongchanagul, et al.
Published: (2024-01-01)

Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes.
by: Dustin M McCraw, et al.
Published: (2023-08-01)

Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.
by: Yuval Avnir, et al.
Published: (2014-05-01)

Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children
by: Juan Manuel Carreño, et al.
Published: (2025-07-01)

Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
by: Hongshuo Song, et al.
Published: (2014-01-01)

Features of influenza virus hemagglutinin genes and their recoding possibilities
by: Eugene P. Kharchenko
Published: (2024-10-01)

Correction for Ramos et al., “Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase”
by: Kevin E. Ramos, et al.
Published: (2025-04-01)

Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies
by: Hua Shi, et al.
Published: (2024-12-01)

A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface
by: Holly C. Simmons, et al.
Published: (2025-06-01)

Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection
by: Jie Mao, et al.
Published: (2025-12-01)

Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses
by: Sasan Fereidouni, et al.
Published: (2023-12-01)

Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance.
by: Bernadeta Dadonaite, et al.
Published: (2024-11-01)

Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin.
by: Ki Joon Cho, et al.
Published: (2014-01-01)

A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization
by: Ziqi Cheng, et al.
Published: (2025-12-01)

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase
by: Amanda K. Rudman Spergel, et al.
Published: (2025-07-01)

Chimeric hemagglutinin and M2 mRNA vaccine for broad influenza subtype protection
by: Dongrong Yi, et al.
Published: (2025-06-01)

Formation of raft-like assemblies within clusters of influenza hemagglutinin observed by MD simulations.
by: Daniel L Parton, et al.
Published: (2013-04-01)

Assessing the effects of a two-amino acid flexibility in the Hemagglutinin 220-loop receptor-binding domain on the fitness of Influenza A(H9N2) viruses
by: Yixue Sun, et al.
Published: (2021-01-01)

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
by: Fatima Amanat, et al.
Published: (2019-01-01)

Role of Nonstructural Proteins and Hemagglutinin Antigens among Patients Suffering from Influenza B Virus
by: Mays Hadi Jebur, et al.
Published: (2025-04-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918.
by: Jun Shen, et al.
Published: (2009-11-01)

Identification of key antigenic sites in hemagglutinin of H10N3 avian influenza virus
by: Zhimin Wan, et al.
Published: (2024-12-01)

Corrigendum to “Leveraging large language models to predict antibody biological activity against influenza A hemagglutinin” [Comput Struct Biotechnol J 27 (2025) 1286–1295]
by: Ella Barkan, et al.
Published: (2025-01-01)

Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018
by: Pedro L. Sanchez, et al.
Published: (2025-06-01)

Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen
by: David Verhoeven, et al.
Published: (2024-12-01)

EFFECTIVENESS OF CROSS-PROTECTIVE RECOMBINANT INFLUENZA VACCINE BASED ON CONSERVED EPITOPES OF VIRAL PROTEINS М2 AND HEMAGGLUTININ
by: L. A. Stepanova, et al.
Published: (2018-01-01)

Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.
by: Guadalupe Ayora-Talavera, et al.
Published: (2009-11-01)

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine
by: Timothy S. Vincent, et al.
Published: (2024-11-01)

Passage of human-origin influenza A virus in swine tracheal epithelial cells selects for adaptive mutations in the hemagglutinin gene
by: Jongsuk Mo, et al.
Published: (2025-01-01)